Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07463547) titled 'Wearable Integration in Symptom Evaluation for Cancer Survivors' on March 5.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Health Services Research. Masking: None (Open Label).

Primary Sponsor: University of Alabama at Birmingham

Condition: Cancer

Intervention: Other: Wearable

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: March 2026

Target Sample Size: 20

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07463547

Published by HT Digital Content Services wi...